Lunai Bioworks Inc (LNAI) Stock Price, Quote & News

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 918 1980

Website: www.lunaibioworks.com

Address:

2080 Century Park East, Suite 906, Los Angeles, United States

AnonymousNYS Mar. 13 at 7:12 PM

$LNAI To be delisted next week right? No Revenue. Trades .17 and needs to be 1.00 to stave off delisting. Thats like 6-7X needed.....Im all about risk when the prospect(s) warrant. Dump this and bring you bags over to NFE (high risk, high reward but better fundamentals). This sounds like Troika, or BETS or TTOO and there are several others Ive been in. The company never does the right thing. Yesterday was the pump/dump from what I can tell. Good luck traders.

1 · Reply

MarketForecasting Mar. 13 at 3:11 PM

$LNAI A scam that fleeced the general public for over half a billion dollars . Short interest continues to rise , unfortunately the short report won’t make it in time before this gets delisted , but I’m willing to bet , short interest will be 30,000,000 by 3/15 report.

0 · Reply

AnonymousNYS Mar. 13 at 2:58 PM

$LNAI lol - as if Dark Pools provide "liquidity". Boy - Not seeing any "liquidity today MM's. Terrible showing compared to yesterday. Well good luck to all you traders here. Seems the fun is over.

0 · Reply

AnonymousNYS Mar. 13 at 2:56 AM

$LNAI This might clear it up: Pre-Market Volume Is Reported Separately Most of the 28M+ shares traded in pre-market (before 9:30 AM). FINRA’s main daily volume figure usually only includes regular-session trading (9:30 AM – 4:00 PM). Pre-market volume often shows up later or on separate tapes.

1 · Reply

Stengaard1 Mar. 12 at 11:36 PM

$LNAI someone ought to investigate this (Nasdaq ?) after cleaning out all the void/fake turnover - it went down from 28 million shares to 5 million shares ...

3 · Reply

MarketForecasting Mar. 12 at 10:45 PM

$LNAI be careful , you are being used for exit liquidity, they are delisting , you don’t furlough , you don’t drop to the teens, you don’t pump pre market and then dump in 30 mins , I repeat resoundingly you are being used for exit liquidity. This will be delisted And lawsuits should ensue .

1 · Reply

AnonymousNYS Mar. 12 at 8:01 PM

$LNAI ouch!!! that didnt end well.

0 · Reply

FatimaMiller553 Mar. 12 at 5:50 PM

$LNAI draws interest as investors follow developments in artificial intelligence and digital automation technologies. AITX highlighted the role of AI-powered analytics and robotics in modern security deployments. https://www.otcmarkets.com/stock/AITX/news/AITXs-RAD-Momentum-Builds-as-Top-25-Healthcare-Network-Adds-Three-More-RIO-Mini-Units?id=511662

0 · Reply

AnonymousNYS Mar. 12 at 5:35 PM

$LNAI I hope traders did well here. This has been awesome to watch. Lets see how things go over the next 24 hours. That 615-630am bit though is totally sus. Good luck to all you traders!!!!!

1 · Reply

AnonymousNYS Mar. 12 at 4:10 PM

$LNAI So the entire float has traded today and supposedly, insiders and banks own it. Thats totally weird.

0 · Reply

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Feb 13, 2026, 8:31 AM EST - 4 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

Feb 9, 2026, 9:15 AM EST - 4 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

Jan 27, 2026, 10:36 AM EST - 6 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

Jan 26, 2026, 9:30 AM EST - 6 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

Dec 18, 2025, 9:00 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

Dec 9, 2025, 7:45 AM EST - 3 months ago

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

Nov 25, 2025, 7:45 AM EST - 3 months ago

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

Nov 5, 2025, 9:22 AM EST - 4 months ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

Oct 30, 2025, 9:32 AM EDT - 4 months ago

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Oct 16, 2025, 9:45 AM EDT - 5 months ago

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

Oct 16, 2025, 9:15 AM EDT - 5 months ago

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 6, 2025, 9:15 AM EDT - 5 months ago

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Sep 30, 2025, 9:15 AM EDT - 5 months ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 25, 2025, 8:30 AM EDT - 6 months ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 24, 2025, 4:50 PM EDT - 6 months ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 11, 2025, 7:00 AM EDT - 6 months ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 9, 2025, 9:12 AM EDT - 6 months ago

Top 3 Health Care Stocks You'll Regret Missing In Q3

SMMT

Sep 9, 2025, 8:47 AM EDT - 6 months ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 8, 2025, 8:50 AM EDT - 6 months ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 4, 2025, 10:05 AM EDT - 6 months ago

Lunai Bioworks Inc. Retains American Defense International

Aug 27, 2025, 9:45 AM EDT - 7 months ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 8, 2025, 10:45 AM EDT - 7 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Jul 28, 2025, 10:38 AM EDT - 8 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 17, 2025, 9:15 AM EDT - 8 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 9, 2025, 8:00 AM EDT - 8 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jun 30, 2025, 9:21 AM EDT - 9 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 3, 2025, 9:15 AM EDT - 10 months ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

May 22, 2025, 3:12 PM EDT - 10 months ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 10 months ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 14, 2025, 9:15 AM EDT - 10 months ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 13, 2025, 9:15 AM EDT - 10 months ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Apr 22, 2025, 9:20 AM EDT - 11 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 9, 2025, 9:25 AM EDT - 1 year ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 4, 2025, 9:40 AM EDT - 1 year ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 1 year ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Feb 26, 2025, 1:25 PM EST - 1 year ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 9:15 AM EST - 1 year ago

Renovaro Announces $15 million in Equity Committed

Jan 7, 2025, 6:51 PM EST - 1 year ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

AGPU

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 6, 2025, 9:15 AM EST - 1 year ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Dec 30, 2024, 9:00 AM EST - 1 year ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 23, 2024, 9:00 AM EST - 1 year ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 20, 2024, 3:40 PM EST - 1 year ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 9:00 AM EST - 1 year ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Oct 17, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 16, 2024, 9:28 AM EDT - 1 year ago

Renovaro Announces Strategic Restructuring and Leadership Transition

Sep 13, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 11, 2024, 9:15 AM EDT - 1 year ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

AnonymousNYS Mar. 13 at 7:12 PM

1 · Reply

MarketForecasting Mar. 13 at 3:11 PM

0 · Reply

AnonymousNYS Mar. 13 at 2:58 PM

$LNAI lol - as if Dark Pools provide "liquidity". Boy - Not seeing any "liquidity today MM's. Terrible showing compared to yesterday. Well good luck to all you traders here. Seems the fun is over.

0 · Reply

AnonymousNYS Mar. 13 at 2:56 AM

1 · Reply

Stengaard1 Mar. 12 at 11:36 PM

$LNAI someone ought to investigate this (Nasdaq ?) after cleaning out all the void/fake turnover - it went down from 28 million shares to 5 million shares ...

3 · Reply

MarketForecasting Mar. 12 at 10:45 PM

1 · Reply

AnonymousNYS Mar. 12 at 8:01 PM

$LNAI ouch!!! that didnt end well.

0 · Reply

FatimaMiller553 Mar. 12 at 5:50 PM

0 · Reply

AnonymousNYS Mar. 12 at 5:35 PM

$LNAI I hope traders did well here. This has been awesome to watch. Lets see how things go over the next 24 hours. That 615-630am bit though is totally sus. Good luck to all you traders!!!!!

1 · Reply

AnonymousNYS Mar. 12 at 4:10 PM

$LNAI So the entire float has traded today and supposedly, insiders and banks own it. Thats totally weird.

0 · Reply

AnonymousNYS Mar. 12 at 4:08 PM

$LNAI Seems .19 is a place it dont want to go. It clsed @ .19 yesterday didnt it? over .19 then maybe someones trade goes into the negative....Definitely interesting to watch.

0 · Reply

11thestate Mar. 12 at 4:08 PM

When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there's some good news. $LNAI / $ENOB investors — you might be surprised, but you actually have a chance to recover your losses. Don't miss it: https://11th.com/cases/enochian-biosciences-investor-settlement

0 · Reply

Stengaard1 Mar. 12 at 3:38 PM

$LNAI Despite a turnover of more than 23 million shares we are - more or less - right back where we started... 2 of my good friends have been using the opportunity this week to make a "tax-sale". Why this manouver ? I am told that in DK you can deduct if you can document that you have lost money, I don't live there anymore so I am unfamiliar with the present tax-rules (Thank God) But I do know that in DK documentation requires proof of sale (and probably not just to your family or friends). You can not (as far as I am told) deduct a loss occurs because the share is delisted from Nasdaq (OTC is not considered a listing in DK), and they were (as most are - even me) unsure/nervous about the consequences of the delisting process. They have in total sold around 200K this week- but bought the last of them back today - actually making a small profit

1 · Reply

stockinvestbull Mar. 12 at 3:22 PM

$LNAI reversal

0 · Reply

AnonymousNYS Mar. 12 at 2:28 PM

$LNAI Do your own DD and start asking about that 10M volume during 6:15 to 6:30 while most couldnt trade unless your on IBK - Webull, etc.....If the SP does go up, it will certainly tell us what that was all about in terms of what sort of liquidity was being put in place during that trade (ie: to the upside or downside). Interesting for sure to watch this.

1 · Reply

AnonymousNYS Mar. 12 at 2:17 PM

$LNAI Definitely not options working in the background either.

0 · Reply

AnonymousNYS Mar. 12 at 2:12 PM

$LNAI Crazy - but my thought is that between 6:15-6:30 - that 9-10M volume was a pumped short position. Meaning the stock was pumped and short positions created there via IBK-Webull type accounts that can trade before 7am. If this were to goto .20+, if my theory is true, those positions would become nervous and begin covering which chaos would ensue. Does not cost anything to think about whats going on.

0 · Reply

AnonymousNYS Mar. 12 at 1:32 PM

$LNAI If the stock already took a 10% hit and closes down 10%+ today, does it go in a short restriction list tomorrow?

0 · Reply

AnonymousNYS Mar. 12 at 1:29 PM

$LNAI @Stengaard1 says most shares are with insiders and danish banks which do not trade PM. What you think of this volume and where it comes from?

1 · Reply

AnonymousNYS Mar. 12 at 1:19 PM

$LNAI im new here but a 265k trading average over 60+ days vs today is something. lol - the china hustle.

0 · Reply

AnonymousNYS Mar. 12 at 1:17 PM

$LNAI WELP - thats a wrap. We at least know there are no real tradable shares today. The rest is dark pools for the day given the SM float size.......Just sell and be acquired or something and this will all be over. The IP is worth something to Pharma if its worth the ink its printed on. lol - this situation is too phunny.

0 · Reply

AnonymousNYS Mar. 12 at 1:03 PM

$LNAI LOL - float has almost traded 1X and market isnt even open.....laughable

1 · Reply

Market Cap	4.46M
Revenue (ttm)	0.00
Net Income (ttm)	-178.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,235,800
Avg Vol	871,134
Day's Range	N/A - N/A
Shares Out	24.19M
Stochastic %K	13%
Beta	0.56
Analysts	Strong Buy
Price Target	N/A